Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer

Final draft guidance

Final appraisal document (PDF 244 KB)

Committee papers (PDF 968 KB)

Appraisal consultation document (PDF version) (PDF 257 KB)

Committee papers (PDF 7.37 MB)

Lung cancer (non-small cell) - nintedanib: equality impact assessment - guidance development (PDF 82 KB)

Lung cancer (non-small cell) - nintedanib: equality impact assessment - scoping (PDF 122 KB)

Lung cancer - nintedanib: final scope (PDF 32 KB)

Lung cancer - nintedanib: final matrix (PDF 101 KB)

Lung cancer - nintedanib: response to consultee and commentator comments on the draft scope and provisional matrix (PDF 157 KB)

Lung cancer - nintedanib: draft scope for consultation (pre-referral) - August 2013 (PDF 107 KB)

Lung cancer - nintedanib: provisional matrix (pre-referral) - August 2013 (PDF 97 KB)